Robert Califf narrowly confirmed FDA commissioner
The Senate on Tuesday confirmed Robert Califf as commissioner of the Food and Drug Administration, a key agency overseeing the U.S. response to the COVID-19 pandemic. The FDA had been without a permanent chief for 13 months. The vote was 50 to 46; with four Democrats and Sen. Bernie Sanders (I-Vt.) voting against Califf and six Republicans supporting his confirmation.
When President Biden nominated Califf, a cardiologist and expert in clinical trials, in November, the White House envisioned an easy confirmation, given that the Senate voted 89-4 to approve his first, brief stint as FDA chief in 2016. But some Democrats expressed concern that he would not be tough enough on the drugmakers because of his industry ties, and many Republicans voted no because of pressure from abortion advocates angry over the FDA's moves to broaden access to the abortion pill.
The White House put in a lot of effort to get Califf across the finish line, including having him meet with more than a dozen senators to address their concerns. Califf will now help steer key decisions on COVID-19 vaccines — including whether to approve vaccines for kids under 5 — treatments, and tests, as well as how the FDA regulates tobacco products. But the FDA has a broad reach, regulating "products that account for 20 cents of every dollar spent by consumers," from food to prescription drugs to "medicinal maggots for wound care," The Washington Post notes.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Califf said his focus would be on the COVID-19 response, emergency preparedness, modernizing the FDA, and improving patient protections, The Wall Street Journal reports. Dr. Janet Woodcock, a veteran drug regulator who has led the FDA since January 2021 as acting commissioner, informed staff she will stay on principal deputy commissioner, the FDA's No. 2 position.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
5 fact-checked cartoons about the VP debate
Cartoons Artists take on civil disagreements, admissions, and more
By The Week US Published
-
The Japanese villages where time stood still
The Week Recommends Up to 200 villagers cooperate to thatch a roof in a single day, preserving this beautiful tradition
By The Week UK Published
-
Crossword: October 6, 2024
The Week's daily crossword
By The Week Staff Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published
-
Scottish drug deaths: what's gone wrong?
The Explainer The latest figures show an increase in drug misuse deaths in Scotland
By Richard Windsor, The Week UK Published
-
Mpox: how dangerous is new health emergency?
Today's Big Question Spread of potentially deadly sub-variant more like early days of HIV than Covid, say scientists
By The Week UK Published
-
What is POTS and why is it more common now?
The explainer The condition affecting young women
By Devika Rao, The Week US Published
-
Mushroom edibles are tripping up users
the explainer The psychedelics can sometimes have questionable components
By Devika Rao, The Week US Published
-
Brexit, Matt Hancock and black swans: five takeaways from Covid inquiry report
The Explainer UK was 'unprepared' for pandemic and government 'failed' citizens with flawed response, says damning report
By Harriet Marsden, The Week UK Published
-
Rapamycin: the popular drug for longevity among biohackers
Under the Radar Living longer may be getting easier
By Devika Rao, The Week US Published
-
Pharmaceutical companies are warning of a rise in knockoff drugs
Under the Radar The World Health Organization is also urging consumers to be cautious
By Justin Klawans, The Week US Published